BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8825834)

  • 21. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O; Kurtz G; Müller-Felber W; Modell S
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic malignant syndrome.
    Yasugi S; Garg V; Been G; Magoulas P
    Aust N Z J Psychiatry; 2010 Jun; 44(6):584. PubMed ID: 20482421
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome after neuroleptic discontinuation.
    Amore M; Zazzeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. All elevated creatine kinase is not neuroleptic malignant syndrome.
    Maniam T; Rahman MA
    Med J Malaysia; 1994 Sep; 49(3):252-4. PubMed ID: 7845275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuroleptic malignant syndrome].
    Dahm JB; Trenckmann U
    Med Klin (Munich); 1991 Nov; 86(11):601-4. PubMed ID: 1685215
    [No Abstract]   [Full Text] [Related]  

  • 27. Neuroleptic malignant syndrome: a preventive program.
    Fernando ML; Manchanda R; Kirk C
    J Psychiatry Neurosci; 1992 Mar; 17(1):31-3. PubMed ID: 1349827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic treatment of hospitalized patients with schizoaffective disorder.
    Flynn J; Grieger TA; Benedek DM
    Psychiatr Serv; 2002 Jan; 53(1):94-6. PubMed ID: 11773657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia.
    Vieweg V; Pandurangi A; Levenson J; Silverman J
    Int J Psychiatry Med; 1994; 24(4):275-303. PubMed ID: 7737786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Water intoxication associated with nephrogenic diabetes insipidus secondary to lithium: case report.
    De Soto MF; Griffith SR; Katz EJ
    J Clin Psychiatry; 1985 Sep; 46(9):402-3. PubMed ID: 3928603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic malignant syndrome in children and adolescents.
    Ty EB; Rothner AD
    J Child Neurol; 2001 Mar; 16(3):157-63. PubMed ID: 11305682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous administration of lisuride in the treatment of neuroleptic malignant syndrome.
    de Mari M; Lamberti P; Simone F; Iliceto G; Federico F; Ferrari E
    Funct Neurol; 1991; 6(3):285-8. PubMed ID: 1683852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Series of seizures as a sign of development of recurrent malignant neuroleptic syndrome - a case report.
    Supe S; Matijević V; Kondić L; Alvir D
    Psychiatr Danub; 2006 Jun; 18(1-2):97-101. PubMed ID: 16804507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurotoxicity related to lithium-risperidon combination treatment in a patient with schizoaffective disorder].
    Böker H; Brandenberger M; Schopper C
    Psychiatr Prax; 2007 Jan; 34(1):38-41. PubMed ID: 17106843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychosis and water intoxication.
    Rosenbaum JF; Rothman JS; Murray GB
    J Clin Psychiatry; 1979 Jul; 40(7):287-91. PubMed ID: 457618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Differential diagnosis of malignant hyperthermia, febrile catatonia and neuroleptic malignant syndrome. A case comparison].
    Schröder J; Linge C; Wähner A
    Fortschr Neurol Psychiatr; 1988 Mar; 56(3):97-101. PubMed ID: 2896144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoxetine and neuroleptic malignant syndrome.
    Halman M; Goldbloom DS
    Biol Psychiatry; 1990 Sep; 28(6):518-21. PubMed ID: 2223920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
    Sczesni B; Becker H; Schröder J; Bittkau S; von Baumgarten F; Truong DD; Przuntek H
    Wien Klin Wochenschr; 1991; 103(1):21-6. PubMed ID: 1673042
    [No Abstract]   [Full Text] [Related]  

  • 40. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.